Chris Bahl

Chris Bahl is an accomplished professional in the field of biochemistry, currently serving as President, Chief Scientific Officer, and Co-Founder of AI Proteins since November 2021, where Bahl also holds a position on the Board of Directors. In addition to this role, Bahl is a Scientific Advisor for BioLoomics, Inc., and Applied Photophysics. Bahl has been associated with Boston Children's Hospital in the Division of Hematology/Oncology and has held a lecturer position at Harvard Medical School since September 2018. Previous roles include Scientific Advisor at OncoPep, Inc. and Vestaron Corporation, as well as Head of Protein Design at the Institute for Protein Innovation. Bahl's academic credentials include a PhD in Biochemistry from the Geisel School of Medicine at Dartmouth, a MS in Biochemistry from the University of Maine, and a BS in Biochemistry, Molecular & Cellular Biology from the same institution. Additionally, Bahl was recognized as a TED Fellow in 2019.